Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

While GLP-1 medications like Ozempic and Wegovy have garnered significant attention, bariatric surgery continues to ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...